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Summary: Changes in amino acid concentrations in plasma during a 100 g oral glucose tolerance test were
investigated in patients with liver cirrhosis and in healthy controls. In the controls, almost all amino acid
concentrations reached a nadir about 3 hours after glucose loading, then returned to initial levels after 6
hours. Immunoreactive insulin levels reached a peak about 30 minutes aftef loading, then decreased gradually,
reaching initial levels after 6 hours. In the controls, the decrease ratios/defined äs maximum decrease during
the 3 hours after loading/initial concentration in plasma, were 0.607 and 0.554 for isoleucine (Ile) and leucine
(Leu) respectively and 0.382 for valine (Val) which is significantly lower than for Ile or Leu. A similar
tendency was recognized in patients with liver cirrhosis. The initial concentration of tyrosine (Tyr) and
phenylalanine (Phe) in liver cirrhosis was significantly higher and their decrease ratios were significantly
lower than in controls. Though no difference was observed between initial concentrations of tryptophan
(Trp) in controls and liver cirrhosis patients, the decrease ratio of Trp in liver cirrhosis was lower (0.061)
than that of controls (0.279) (p < 0.001).
The value, t-Trp/BCAA + AAA, i.e. total Trp concentration (mmol/l)/concentration (mmol/1) of branched
chain amino acids (BCAA, Ile + Leu + Val) plus aromatic amino acids (AAA, Tyr + Phe), which is known to
correlate with the brain Tip concentration of rats (Fernstrom, J. D. & Wurtman, R. J. (1972) Science 178,
414-416), changed significantly from 9.6 + 2.4 (mean ± l SD) at the initiation to 12.9 ± 3.3 at 3 hours
after loading in contrpls (p <0.001), and in liver cirrhosis it changed from 10.3 + 1.9 to 15.8 ± 3.1 (p
< 0.001). The net increase of the value t-Trp/BCAA+AAA during the 3 hours in liver cirrhosis (0.055 ±
0.026) was significantly higher than in controls (0.031 + 0.021), (p <0.02). The value BCAA/AAA in
controls did not change following glucose loading, but in liver cirrhosis it decreased from l .4 to l .0.
Änderungen der Konzentration der Aminosäuren im Plasma während des oralen Glucosetoleranztests und ihre
Wirkung auf die hepatische Encephalopathie
Zusammenfassung: Die Änderungen der Konzentration der Aminosäuren im Plasma während eines oralen
Glucosetoleranztests mit 100g Glucose wurden bei Patienten mit Lebercirrhose und bei gesunden Kontrollper-
sonen untersucht. Bei den Kontrollpefsonen erreichten fast alle Aminosäuren ihre geringste Konzentration
etwa 3 h nach Glüeosebelastung und zeigten nach 6 h wieder ihre Ausgangskonzentrationen.
Das immunreaktive Insulin erreichte einen Spitzenwert etwa 30 min nach Glüeosebelastung, fiel dann
allmählich ab und hatte nach 6h die Ausgangskonzentration wieder erreicht.
Die maximale Konzentrationsdifferenz der Aminosäuren im Plasma während der 3 h nach Glüeosebelastung
würde als Fraktion der Ausgangskonzentration berechnet. Dieser Quotient betrug bei den Kontrollpersonen
0,607 für Isoleucin und 0,554 für Leucin; er war für Valin mit 0,382 signifikant geringer. Eine ähnliche
Tendenz zeigten Patienten mit Lebercirrhose. Die Ausgangskonzentrationen von Tyrosin und Phenylalanin
waren bei Patienten mit Lebercirrhose signifikant höher und ihre Verringerung war signifikant geringer als
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bei den Kontrollpcrsonen. Obwohl sich die Ausgangskonzentrationen von Tryptophan nicht unterschieden,
war die Verringerung der Konzentration bei Patienten mit Lebercirrhose geringer; der Quotient betrug 0,061
gegenüber 0,279 bei den Kontrollpersonen (p < 0,001).
Der Quotient aus der millimolaren Konzentration des Gesamttryptophans und der Summe der millimolaren
Konzentrationen der verzweigtkettigen und aromatischen Aminosäuren, der mit der Tryptophankonzentration
im Gehirn von Ratten korreliert (Femstrom, J. />. & Wurtman, R. J. (1972) Science /75, 414—416), änderte
sich bei den Kontrollpersonen signifikant von 9,6 ± 2,4 (x ± s) zu Beginn auf 12,9 + 3,3 (p < 0.001) 3h
nach Glucosebelastung, bei den Patienten mit Lebercirrhose signifikant von 10,3 ± 1,9 auf 15,8 ± 3,1 (p
< 0,001). Der Nettoanstieg dieses Konzentrationsquotienten während der 3h nach Glucosebelastung war bei
den Patienten mit Lebercirrhose (0,055 ± 0,026) signifikant (p <0,02) höher als bei den Kontrollpersonen
(0,031 ± 0,021).
Der Quotient aus den millimolaren Konzentrationen aus verzweigtkettigen und aromatischen Aminosäuren
änderte sich nach Glucosebelastung bei den Kontrollpersonen nicht, er fiel jedoch bei den Patienten mit
Lebercirrhose von 1,4 auf 1,0.
Introduction
Plasma tryptophan is often taken into consideration
in hepatic encephalopathy. In some cases of hepatic
encephalopathy, uptake of tryptophan into the brain
increases, followed by an increase of serotonin,
5-hydroxyindole acetic acid and various
pseudoneurotransmitters (2.3).
Fernstrom et al. (4) reported that plasma free
tryptophan (f-Trp) did not correlate with brain
tryptophan in rat but total Trp/branched chain amino
acids + aromatic amino acids (t-Trp/BCAA+AAA)
correlated strongly with brain tryptophan. These
authors also discussed the relation between brain
tryptophan and diurnal variations in plasma amino
acids of patients with liver cirrhosis and healthy con-
trols fed on protein, carbohydrate and mixed diets
(4). We previously reported that plasma free
tryptophan did not correlate with hepatic
encephalopathy (5).
This study was designed to obtain Information con-
cerning preventive foods for hepatic encephalopathy.
Instead of examining diurnal variations in plasma
amino acids during consumption of carbohydrate,
which is the main constituent in a Japanese diet, we
studied changes ofplasma amino acid concentrations,
mainly branched chain amino acids and aromatic
amino acids, during an oral glucose tolerance test in
patients with liver cirrhosis and in healthy controls.
Materials and Methods
Pat ients
Nine healthy male and seven female volunteers ranging from
23 to 42 years old and eleven male and seven females with
compensated liver cirrhosis ranging from 42 to 72 years old
were studied. The diagnosis was based on clinical and lab-
oratory data and on laparoscopy and/or biopsy.
Oral glucose tolerance test
100 g of glucose was administered orally after an overnight fast
to controls and patients. Bloöd was drawn at 0, 0.5, l, 2, 3,
hours after loading from the antecuvital vein, and analysed for
glucose, insulin and glucagon levels. Plasma amino acid was
also assayed (7). In controls, assays were continued up to 6
hours.
Indocyan ine green test
Indocyanine green test was carried out on patients with chrom'c
hepatitis (15), liver cirrhosis (14) and liver cancer (3) while in
a state öf fasting.
Assay procedures
Immunoreactive insulin (IRI) levels were measured by a double
antibody technique (Dainabot). Immunoreactive glucagon
(IRG) was determined by radioimmunpassay using Unger's
30K antibody. IRI/IRG was calculated äs suggested by Muller
et al. (6) using the foilowing formula: IRI/IRG = IRI (mÜ/1)/
IRG(ng/l) 23.33.
The plasma glucose concentration was determined by the hexo-
kinase method.
Plasma amino acids were assayed by high performance liquid
chromatography (Shimazu Corp., Kyoto) using a column filled
with styrene divinylbenzehe polymer sulfonated cation-
exchange resin (7). Details of tryptophan assay were also re-
ported previously (8).
Results
Changes in plasma glucose, insulin and glucagon
Figures l and 2 show changes in plasma glucose,
immunoreactive insulin (IRI), immunoreactive
glucagon (IRG) and IRI/IRG during the oral glucose
tolerance test in patients with liver cirrhosis and in
healthy controls. In the controls plasma glucose and
immunoreactive insulin were maximal after 30 min-
utes, followed by a gradual decrease, reaching the
"basal level at 6 hours after loading. Immunoreactive
glucagon decreased during the fjrst hour after loading
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Fig. 1. Changes in plasma glucose and molar ratio of immunoreactive insulin/immunoreactive glucagon during a 100g oral
glucose tolerance test in patients with liver cirrhosis (Φ, n — 18) and in normal control (O» n = 16). The marks show
significant diflerences from control: **** p <0.001.
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Fig. 2. Changes in plasma immunoreactive insulin and glucagon during a 100g oral glucose tolerance test in patients with liver
cirrhosis (O) and in normal control (O)· The marks show significant difTerences from control: ** p <0.02, *** p <0.01,
**** p < 0.001.
and then gradually recpvered. Compared with con-
trols, patients with liver cirrhosis showed the more
marked and prolonged hyperglycaemia and relative
hyperiflsulinism after oral glucose tolerance test.
Changes in plasma amino acids concentrations during
oral glucose tolerance test
Changes in plasma branched chain amino acids
(BCAA) and aromatic amino acids (AAA) in controls
during oral glucose tolerance test is shown in figure
3. Isoleucine (Ile) and leucine (Leu) deereased, being
minimal about 3 hours after loading and nearly re-
gaining their original levels at 6 hours. However,
valine (Val), which was one of the branched chain
amino acids tested, decreased at a significantly lower
rate and its pattern of change differed from those of
isoleucine and leucine (tab. 1). Tyrosine (Tyr) and
phenylalanine (Phe) were found to change in a similar
pattern (fig. 3). However tryptophan did not decrease
s much s tyrosine and phenylalanine (tab. 1). Al-
most all amino acids including those not shown here
reached a nadir at 3 hours after loading.
The decrease ratio and the initial concentrations are
listed in tablel. The initial concentrations of
branched chain amino acids in patients with liver
cirrhosis were significantly lower and tyrosine and
phenylalanine were higher than in controls. The
decrease ratio of isoleucine and leucine were higher,
and those of tryptophan, tyrosine and phenylalanine
were lower in patients with liver cirrhosis than in
controls.
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Fig. 3. Changes in branched chain amino acids (BCAA), aromatic araino acids (AAA) and tryptophan in heaithy control during
100g oral glucose tolerance test.
Tab. 1. Concentrations and decrease ratio of plasma amino acids during a 100g oral giucose tolerance test in normal controls



















































Decrease ratio: maximum decrease during 3 hours after load/initial concentration.
Values: Mean ± l SD. Studenfs t-test was applied, assuming a normal distribution of these values.im samples tested.
Significant difference from control * p <0.05, ** p <0.02, *** p <0.01, **** p < 0.001. Significant difference from valine ° p
< 0.001
Changes in t-Trp/BCAA + AAA and BCAA/AAA dur-
ing oral glucose tolerance test
Table 2 shows the ratio of t-Trp/BCAA+AAA in a
fasting state and 3 hours after loading in patients
with liver cirrhosis and in controls; the ratio after
Tab. 2. Change of t-Trp/BCAA + A A A of plasma during 100g
oral glucose tolerance test.
Before 3 hours Net increase
Control 0.096 ± 0.024 0.129 ± 0.033° 0.031 ± 0.021





Net increase: t-Trp/BCAA + AAA at 3 hours after load 
that of fasted states.
Significant difference from control: * p <0.05, ** p <0.02,
Significant difference from the initial value: ° p < 0.001.
loading was elevated significantly in both cases, and
the net increase for liver cirrhosis (0.055) was higher
(p <0.02) than that for controls (0.031). The change
of the BCAA/AAA ratio by glucose loading is shown
in table 3, It decreased in liver cirrhosis bmt did not
change in controls. The relationship between BCAA/
AAA (fasting state) and indocyanine green test was
examined (flg. 4), and a good correlation was found
(r = -0.8045, y = -0.077x + 4.24, p <0.01, ri =
33).
Tab. 3. Change of BCAA/AAA of plasma during oral glucose
tolerance test.







Significant difference from the ii t&l v lue, * p <0.1.
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Fig. 4. Relation between branched chain amino acids (BCAA)/
aromatic amino acids (AAA) ratio of plasma before
loading of glucose and the retention ratio of in-
docyanine green at 15 min after injection in patients
with liver diseases. O chronic Hepatitis, Δ liver cancer,
O Hver cirrhosis. y = -0.077x -h 4.24, r = -0.8045,
p <0.01 (n = 33).
Discussion
We loaded 100 g of glucose orally to patients with
liver cirrhosis and controls, and changes of plasma
amino acids during the oral glucose tolerance test
were examined. After the oral glucose tolerance test,
the ratio t-Trp/BCAA+AAA was observed to in-
crease in patients with liver cirrhosis and controls
and moreover its net increase was higher (p < 0.02)
in liver cirrhosis than in controls. The ratio, branched
chain amino acids/aromatic amino acids (BCAA/
AAA), was found to decrease slightly in all patients
with liver cirrhosis at 3 hours after loading, and the
same tendency was observed in patients with chronic
hepatitis and liver cancer (data not shown).
Marchesini et al. (9) performed the same experiments
and observed an increase in the ratio plasma insulin/
glucagon, thereby improving the catabolic state. They
emphasized that f-Trp/BCAA + AAA decreased in
patients with liver cirrhosis after the oral glucose
tolerance test, and c iicluded that the oral glueose
tolerance test was more effective in patients with liver
cirrhosis than in controls in brijiging about recovery
from hepatic encephalopathy. But the authors had
fractionated the free tryptophan by centrifugation
without pH control, and the tryptophan de-
termination was carried out by the Denckla & Dewey
method (10) which has been reported to have wide
margin of error (l 1). Although we did not measure f-
Trp/BCAA +AAA in the present study, Fernstrom &
Wurtman (1) reported that plasma t-Trp/BCAA+
AAA shows a strong positive correlation with brain
tryptophan concentrations among healthy rats after
consumption of carbohydrates, but that plasma free
tryptophan is not correlated with brain tryptophan.
In our previous study (5), no significant difference in
plasma free tryptophan concentration was observed
between liver cirrhosis patients with or without
hepatic encephalopathy, and plasma free tryptophan
was significantly higher in liver cirrhosis with bleed-
ing tendency than in without bleeding tendency.
Cummings et al. (12) showed tryptophan and 5-hy-
droxyindole acetic acid in brain to be significantly
elevated in portocaval anastomosed rats s compared
with control rats and that administration of branched
chain amino acids caused brain indoles to decrease
toward normal levels. This result may reasonably
explain why the administration of branched chain
amino acids lowered the ratio of t-Trp/BCAA + AAA
in plasma, accompanied by decreased uptake of
tryptophan into brain. By taking account of these
results and our present study, oral glucose tolerance
test in cases of liver cirrhosis might increase the
risk of hepatic encephalopathy. Lowering the BCAA/
AAA by oral glucose tolerance test has an opposite
effect to that of infusing special amino acids enriched
with branched chain amino acids to assist recovery
from hepatic encephalopathy. Although BCAA/AAA
did not necessarily correlate to consciousness levels,
its value usually feil with the progress of hepatic
failure.
Morgan et al. (13) asserted that the BCAA/AAA
ratio showed a good correlation with the histolog-
ically judged severity of liver diseases. In the present
study a strong negative correlation between BCAA/
AAA and indocyanine green retention ratio was
recognized (fig. 4). If we assume that BCAA/AAA is
negatively correlated with the permeability of the
blood brain barrier, and indocyanine green retention
ratio correlates inversely with liver function, patients
whose BCAA/AAA is low would face an increased
risk of hepatic encephalopathy, due to the increase
in uptake of tryptophan, aromatic amino acids and
other substances related to hepatic encephalopathy.
Considering the net increase of t-Trp/BCAA H-AAA
during oral glucose tolerance test, which was 0.031
in controls and 0.055 in patients with liver cirrhosis,
entry of tryptophan into the brain would be elevated
in patients with liver cirrhosis. The increased uptake
of tryptophan by the brain might result in the brain
becoming oedematous, followed by disturbances to
the permeability of the blood brain barrier. In fact
Hirayama reported that an oral tryptophan load
evoked drowsiness, dizziness and nausea in patients
with liver cirrhosis more severely than in controls,
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suggesting that brain tryptophan is increased much
more readily in patients with liver cirrhosis (3). Dur-
ing our study, almost all subjects complained of
drowsiness or even slept. Närvänen (14) reported that
some healthy volunteers showed tiredness and loss
of concentration after oral glucose tolerance test,
possibly because the increase of serotonin in whole
blood resulted in its decrease in the neurons.
Generally, much attention has been paid to protein
diets for protection against hepatic encephalopathy.
However attention must also be paid to carbohydrate
diets. The possibility of hepatic encephalopathy inight
be enhanced by continuously giving carbohydraies to
patients with liver cirrhosis without braiiched chain
amino acid Supplements.
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